Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi (IST:ONCSM)

Turkey flag Turkey · Delayed Price · Currency is TRY
295.00
+4.25 (1.46%)
At close: Feb 9, 2026
Market Cap7.04B +159.2%
Revenue (ttm)527.38M +11.6%
Net Income32.46M
EPS1.36
Shares Out23.85M
PE Ratio216.77
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume327,799
Average Volume836,479
Open291.00
Previous Close290.75
Day's Range291.00 - 298.25
52-Week Range76.00 - 376.00
Beta1.01
RSI47.47
Earnings DateFeb 18, 2026

About IST:ONCSM

Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi manufactures and sells chemotherapy drug preparation kits, medical devices, and test kits in Turkey. The company offers OncoCare Monolitik, an automated chemotherapy drug preparation device; OncoCare Plus, a chemotherapy drug guide; OncoWaste and M-Waste, a hazardous waste sealing system, chemotherapy drugs, cephalosporins, penicillins, infectious waste and toxic laboratory waste; OncoCare Set, a chemotherapy preparation and administration consumables; and Oncocare Infusion Pump. It a... [Read more]

Sector Healthcare
Founded 2008
Employees 358
Stock Exchange Istanbul Stock Exchange
Ticker Symbol ONCSM
Full Company Profile

Financial Performance

In 2024, IST:ONCSM's revenue was 374.49 million, an increase of 7.85% compared to the previous year's 347.24 million. Losses were -59.17 million, -48.65% less than in 2023.

Financial Statements